Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics -On Feb 28, Got Second Letter From Nasdaq Stating Co Had Been Granted Additional 180 Days To Regain Compliance With Nasdaq

March 6 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS -ON FEB 28, GOT SECOND LETTER FROM
NASDAQ
STATING CO HAD BEEN GRANTED ADDITIONAL 180 DAYS TO REGAIN
COMPLIANCE WITH NASDAQ


Further company coverage:  EFTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news